▶ 調査レポート

血管損傷治療の世界市場:市場規模、シェア、成長、動向、予測

• 英文タイトル:Vascular Injury Treatment Market (Injury: Spasm, Thrombosis, Contusion/Intimal Flap, Laceration/Transection, Arteriovenous (AV) Fistula, Aneurysm & Pseudoaneurysm, and Others; Treatment: Lateral Arteriorrhaphy/ Venorrhaphy, Patch Angioplasty, Bypass Graft, Extraanatomic Bypass, Thrombectomy, and Others; End User: Hospitals, Ambulatory Surgical Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。血管損傷治療の世界市場:市場規模、シェア、成長、動向、予測 / Vascular Injury Treatment Market (Injury: Spasm, Thrombosis, Contusion/Intimal Flap, Laceration/Transection, Arteriovenous (AV) Fistula, Aneurysm & Pseudoaneurysm, and Others; Treatment: Lateral Arteriorrhaphy/ Venorrhaphy, Patch Angioplasty, Bypass Graft, Extraanatomic Bypass, Thrombectomy, and Others; End User: Hospitals, Ambulatory Surgical Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027 / TPM-NV056資料のイメージです。• レポートコード:TPM-NV056
• 出版社/出版日:Transparency Market Research / 2019年10月22日
• レポート形態:英文、PDF、194ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥764,940 (USD5,795)▷ お問い合わせ
  Multi User¥1,160,940 (USD8,795)▷ お問い合わせ
  Global Site License¥1,556,940 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、血管損傷治療の世界市場について調べ、血管損傷治療の世界市場規模、市場動向、市場シェア、市場環境、市場予測、傷害別(けいれん、血栓症、挫傷/内膜皮弁、裂傷/離断、動静脈(AV)瘻孔、動脈瘤および偽動脈瘤、およびその他)分析、治療別(側方後方/静脈瘤、パッチ血管形成術、バイパス移植、解剖学的バイパス、血栓切除、およびその他)分析、エンドユーザー別(病院、外来手術センター、その他)分析、関連企業情報などをまとめました。
・血管損傷治療の市場概要
・血管損傷治療の市場動向
・血管損傷治療の世界市場規模・予測
・血管損傷治療市場:傷害別(けいれん、血栓症、挫傷/内膜皮弁、裂傷/離断、動静脈(AV)瘻孔、動脈瘤および偽動脈瘤、およびその他)
・血管損傷治療市場:治療別(側方後方/静脈瘤、パッチ血管形成術、バイパス移植、解剖学的バイパス、血栓切除、およびその他)
・血管損傷治療市場:治療別(側方後方/静脈瘤、パッチ血管形成術、バイパス移植、解剖学的バイパス、血栓切除、およびその他)
・地域別分析(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争環境・関連企業分析

Vascular Injury Treatment Market – Scope of the Report

A latest research report published by Transparency Market Research (TMR) measures the impact of the crucial indicators that drive the growth of the vascular injury treatment market during the forecast period of 2019-2027. This comprehensive report on the global vascular injury treatment market is an in-depth overview of the vascular injury treatment market, covering crucial aspects, segmentation based on various parameters, and the competitive landscape. This exclusive study also sheds light on the research methodologies followed in order to arrive at precise market numbers. This business study also includes relevant charts and tables so as to enable stakeholders in getting a clear perspective of the vascular injury treatment market.

This statistical research report studies, at length, the key insights culled by this business study. With the help of rare and distinguished insights covered in this research report, stakeholders in the vascular injury treatment market can devise sustainable strategies and gain an upper hand over their competitors. Numerous factors responsible for the vascular injury treatment market’s upward growth are also studied at length in this comprehensive research report. In addition to this, the report lists down and explains the key drivers, threats, restraints, and opportunities available in the vascular injury treatment market.

This comprehensive study of the global market for vascular injury treatment analyzes the growth drivers as well as restraints at length. This exclusive study of crucial factors can assist market participants in comprehending the challenges present in the vascular injury treatment market during the forecast period of 2019-2027. The research report also gauges the threat from new market entrants, and the degree of competition present in the vascular injury treatment market. The influence exerted on the vascular injury treatment market by government policies is also covered in this research report.

Vascular Injury Treatment Market – Key Questions Answered

This research report assesses and answers key questions pertaining to the growth of the vascular injury treatment market during the forecast period. Some of the significant questions answered in this research report include:

What are the recent developments and crucial market shifts observed in the vascular injury treatment market during the forecast period?
Which treatment is projected for incremental opportunities in the vascular injury treatment market?
What are the crucial strategies followed by market players operating in the vascular injury treatment market?
What are some of the recent developments that new market participants should look at in the vascular injury treatment market?
Vascular Injury Treatment Market – Research Methodology

Research conducted by analysts of Transparency Market Research (TMR) comprises a systematic approach, with a view to obtain important insights into the vascular injury treatment market for the forecast period of 2019-2027. Interviews and discussions conducted with key market participants, opinion leaders, vendors, distributors, and industry experts are also included in the study. Additionally, an in-depth secondary study of company websites, marketing collaterals, industry associations, and government statistics is also carried out.

Vascular Injury Treatment Market – Segmentation

This exclusive research report encompasses the technological advancements as well as recent trends in order to get a better perspective regarding the growth of the vascular injury treatment market. In order to help market participants get a precise market understanding, our analysts have segregated the vascular injury treatment market into key segments – injury, treatment, end user, and region.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Vascular Injury Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Vascular Injury Treatment Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. Reimbursement Scenario

5.2. Regulatory Scenario

5.3. Technological Advancements

5.4. Number of Vascular Injury Incidences, by Region, (2018)

5.4.1. Penetrating Wounds

5.4.2. Blunt Trauma

5.4.3. Invasive Procedures

6. Global Vascular Injury Treatment Market Analysis and Forecast, by Injury

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Injury, 2017–2027

6.3.1. Spasm

6.3.2. Thrombosis

6.3.3. Contusion/Intimal Flap

6.3.4. Laceration/Transection

6.3.5. Arteriovenous (AV) Fistula

6.3.6. Aneurysm and Pseudoaneurysm

6.3.7. Others

6.4. Market Attractiveness, by Injury

7. Global Vascular Injury Treatment Market Analysis and Forecast, by Treatment

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Treatment, 2017–2027

7.3.1. Lateral Arteriorrhaphy/ Venorrhaphy

7.3.2. Patch Angioplasty

7.3.3. Bypass Graft

7.3.4. Extraanatomic Bypass

7.3.5. Thrombectomy

7.3.6. Others

7.4. Market Attractiveness, by Treatment

8. Global Vascular Injury Treatment Market Analysis and Forecast, by End User

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by End User, 2017–2027

8.3.1. Hospitals

8.3.2. Ambulatory Surgical Centers

8.3.3. Others

8.4. Market Attractiveness, by End User

9. Global Vascular Injury Treatment Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Market Attractiveness, by Country/Region

10. North America Vascular Injury Treatment Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Market Value Forecast, by Injury, 2017–2027

10.2.1. Spasm

10.2.2. Thrombosis

10.2.3. Contusion/Intimal Flap

10.2.4. Laceration/Transection

10.2.5. Arteriovenous (AV) Fistula

10.2.6. Aneurysm and Pseudoaneurysm

10.2.7. Others

10.3. Market Value Forecast, by Treatment, 2017–2027

10.3.1. Lateral Arteriorrhaphy/ Venorrhaphy

10.3.2. Patch Angioplasty

10.3.3. Bypass Graft

10.3.4. Extraanatomic Bypass

10.3.5. Thrombectomy

10.3.6. Others

10.4. Market Value Forecast, by End User, 2017–2027

10.4.1. Hospitals

10.4.2. Ambulatory Surgical Centers

10.4.3. Others

10.5. Market Value Forecast, by Country, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. Market Attractiveness Analysis

10.6.1. By Injury

10.6.2. By Treatment

10.6.3. By End User

10.6.4. By Country

11. Europe Vascular Injury Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Market Value Forecast, by Injury, 2017–2027

11.2.1. Spasm

11.2.2. Thrombosis

11.2.3. Contusion/Intimal Flap

11.2.4. Laceration/Transection

11.2.5. Arteriovenous (AV) Fistula

11.2.6. Aneurysm and Pseudoaneurysm

11.2.7. Others

11.3. Market Value Forecast, by Treatment, 2017–2027

11.3.1. Lateral Arteriorrhaphy/ Venorrhaphy

11.3.2. Patch Angioplasty

11.3.3. Bypass Graft

11.3.4. Extraanatomic Bypass

11.3.5. Thrombectomy

11.3.6. Others

11.4. Market Value Forecast, by End User, 2017–2027

11.4.1. Hospitals

11.4.2. Ambulatory Surgical Centers

11.4.3. Others

11.5. Market Value Forecast, by Country/Sub-region, 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Market Attractiveness Analysis

11.6.1. By Injury

11.6.2. By Treatment

11.6.3. By End User

11.6.4. By Country/Sub-region

12. Asia Pacific Vascular Injury Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast, by Injury, 2017–2027

12.2.1. Spasm

12.2.2. Thrombosis

12.2.3. Contusion/Intimal Flap

12.2.4. Laceration/Transection

12.2.5. Arteriovenous (AV) Fistula

12.2.6. Aneurysm and Pseudoaneurysm

12.2.7. Others

12.3. Market Value Forecast, by Treatment, 2017–2027

12.3.1. Lateral Arteriorrhaphy/ Venorrhaphy

12.3.2. Patch Angioplasty

12.3.3. Bypass Graft

12.3.4. Extraanatomic Bypass

12.3.5. Thrombectomy

12.3.6. Others

12.4. Market Value Forecast, by End User, 2017–2027

12.4.1. Hospitals

12.4.2. Ambulatory Surgical Centers

12.4.3. Others

12.5. Market Value Forecast, by Country/Sub-region, 2017–2027

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Market Attractiveness Analysis

12.6.1. By Injury

12.6.2. By Treatment

12.6.3. By End User

12.6.4. By Country/Sub-region

13. Latin America Vascular Injury Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast, by Injury, 2017–2027

13.2.1. Spasm

13.2.2. Thrombosis

13.2.3. Contusion/Intimal Flap

13.2.4. Laceration/Transection

13.2.5. Arteriovenous (AV) Fistula

13.2.6. Aneurysm and Pseudoaneurysm

13.2.7. Others

13.3. Market Value Forecast, by Treatment, 2017–2027

13.3.1. Lateral Arteriorrhaphy/ Venorrhaphy

13.3.2. Patch Angioplasty

13.3.3. Bypass Graft

13.3.4. Extraanatomic Bypass

13.3.5. Thrombectomy

13.3.6. Others

13.4. Market Value Forecast, by End User, 2017–2027

13.4.1. Hospitals

13.4.2. Ambulatory Surgical Centers

13.4.3. Others

13.5. Market Value Forecast, by Country/Sub-region, 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Market Attractiveness Analysis

13.6.1. By Injury

13.6.2. By Treatment

13.6.3. By End User

13.6.4. By Country/Sub-region

14. Middle East & Africa Vascular Injury Treatment Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Market Value Forecast, by Injury, 2017–2027

14.2.1. Spasm

14.2.2. Thrombosis

14.2.3. Contusion/Intimal Flap

14.2.4. Laceration/Transection

14.2.5. Arteriovenous (AV) Fistula

14.2.6. Aneurysm and Pseudoaneurysm

14.2.7. Others

14.3. Market Value Forecast, by Treatment, 2017–2027

14.3.1. Lateral Arteriorrhaphy/ Venorrhaphy

14.3.2. Patch Angioplasty

14.3.3. Bypass Graft

14.3.4. Extraanatomic Bypass

14.3.5. Thrombectomy

14.3.6. Others

14.4. Market Value Forecast, by End User, 2017–2027

14.4.1. Hospitals

14.4.2. Ambulatory Surgical Centers

14.4.3. Others

14.5. Market Value Forecast, by Country/Sub-region, 2017–2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Market Attractiveness Analysis

14.6.1. By Injury

14.6.2. By Treatment

14.6.3. By End User

14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Company Profiles

15.1.1. Cleveland Clinic

15.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.1.2. Company Financials

15.1.1.3. Growth Strategies

15.1.1.4. SWOT Analysis

15.1.2. Apollo Hospitals Enterprise Ltd.

15.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.2.2. Company Financials

15.1.2.3. Growth Strategies

15.1.2.4. SWOT Analysis

15.1.3. Massachusetts General Hospital

15.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.3.2. Company Financials

15.1.3.3. Growth Strategies

15.1.3.4. SWOT Analysis

15.1.4. Heidelberg University Hospital

15.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.4.2. Company Financials

15.1.4.3. Growth Strategies

15.1.4.4. SWOT Analysis

15.1.5. Royal Berkshire NHS Foundation Trust

15.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.5.2. Company Financials

15.1.5.3. Growth Strategies

15.1.5.4. SWOT Analysis

15.1.6. Universal Health Services, Inc.

15.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.6.2. Company Financials

15.1.6.3. Growth Strategies

15.1.6.4. SWOT Analysis

15.1.7. Tenet Healthcare

15.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.7.2. Company Financials

15.1.7.3. Growth Strategies

15.1.7.4. SWOT Analysis

15.1.8. Mayo Clinic Health System

15.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.8.2. Company Financials

15.1.8.3. Growth Strategies

15.1.8.4. SWOT Analysis

15.1.9. Mediclinic International

15.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.9.2. Company Financials

15.1.9.3. Growth Strategies

15.1.9.4. SWOT Analysis

15.1.10. CHSPSC, LLC

15.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.10.2. Company Financials

15.1.10.3. Growth Strategies

15.1.10.4. SWOT Analysis

15.1.11. IHH Healthcare Berhad

15.1.11.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.11.2. Company Financials

15.1.11.3. Growth Strategies

15.1.11.4. SWOT Analysis

*Note: Financial details for companies that do not report this information in public domain might not be captured

List of Tables

Table 01: Number of Vascular Injury Incidences, by Region, 2018
Table 02: North America Number of Vascular Injury Incidences, 2018
Table 03: Europe America Number of Vascular Injury Incidences, 2018
Table 04: Asia Pacific Number of Vascular Injury Incidences, 2018
Table 05: Latin America Number of Vascular Injury Incidences, 2018
Table 06: Middle East & Africa Number of Vascular Injury Incidences, 2018
Table 07: Global Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Injury, 2017–2027
Table 08: Global Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 09: Global Vascular Injury Treatment Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 10: Global Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 11: North America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 12: North America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Injury, 2017–2027
Table 13: North America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 14: North America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 15: Europe Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Europe Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Injury, 2017–2027
Table 17: Europe Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 18: Europe Vascular Injury Treatment Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 19: Asia Pacific Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
Table 20: Asia Pacific Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Injury, 2017–2027
Table 21: Asia Pacific Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 22: Asia Pacific Vascular Injury Treatment Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 23: Latin America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Latin America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Injury, 2017–2027
Table 25: Latin America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 26: Latin America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 27: Middle East & Africa Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
Table 28: Middle East & Africa Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Injury, 2017–2027
Table 29: Middle East & Africa Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 30: Middle East & Africa Vascular Injury Treatment Market Value (US$ Mn) Forecast, by End User, 2017?2027